15 January 2019
Gendius announces launch of Intellin®
Diabetes app to prevent complications from diabetes … Alderley Park, UK – 10th January 2019 … The NHS spends 10% of its budget or £14 billion on treating diabetes and its complications. Today Gendius announced the availability of Intellin® on the Google Play and...
4 January 2019
Peter Hamer joins SurgaColl as Chief Executive Officer
Alderley Park, UK – 10th December 2018. SurgaColl, a regenerative medicine company, today announced the appointment of Peter Hamer as Chief Executive Officer. Mr. Hamer succeeds Bill Allan as CEO following Bill’s decision to retire from full time executive roles.
20 December 2018
Maxwellia expand their team with two new appointments
Maxwellia has expanded their team of switch experts with two new appointments following their relocation to the Alderley Park Accelerator. Maxwellia, the UK’s only ‘prescription to over the counter (OTC)’ medicines company, has expanded their team of switch...
13 December 2018
Oxford BioTherapeutics Expands Strategic Collaboration with WuXi Biologics
Shanghai China and Oxford UK, December 11, 2018 –WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing and Oxford BioTherapeutics Ltd.
3 December 2018
Med-Tech companies triumph at the Bionow Awards
The outstanding companies and leaders of the North’s life sciences sector – which is worth more than £13bn to the economy- were honoured last night at the 17th annual Bionow Awards. More than 300 people attended the awards dinner in Cheshire, which saw medical...
22 November 2018
Blueberry Therapeutics Announce Positive Results from a Phase I-II Clinical Trial
Alderley Park, UK, 21stNovember 2018– Blueberry Therapeutics Limited (“Blueberry Therapeutics”), a modern drug discovery and development company committed to the development of innovative new therapies for the treatment of common and difficult to treat...
19 November 2018
Biofilm seals £2.5m funding injection
Biofilm has secured a £2.5 million funding package to increase production capacity and expand its product range. Biofilm, which was originally launched as a subsidiary of food products firm Devro, specialises in fast dissolving and absorbable films for use in food...
19 November 2018
R2C Online wins at 2018 Commercial Motor Awards
Delighted to announce that Catapult portfolio company R2C Online have won the award for Workshop Innovation of the Year at the 2018 Commercial Motor Awards. Read more about the event and the winners here:
8 November 2018
YProtech receives £400k funding boost
A high value chemistry services company based at Alderley Science Park has secured £400,000 of funding. YProtech (YPT) was founded in 2011. The core of the company's business relates to those operating in the pharmaceutical, biotechnology and applied chemistry...
10 October 2018
UMI3 Ltd showcases innovations to Catapult Ventures
Investors meet University of Manchester academic entrepreneurs … On 3rd October UMI3 Ltd held an investor day with Catapult Ventures, who manage the Greater Manchester & Cheshire Life Sciences Fund, to hear from the CEOs of two of their portfolio companies and to showcase a...